Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT03524222
Other study ID # 2017P002583
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date January 18, 2018
Est. completion date September 2023

Study information

Verified date September 2021
Source Brigham and Women's Hospital
Contact David M Levine, MD MPH MA
Phone 617-732-7063
Email dmlevine@partners.org
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The investigators propose a home hospital model of care that substitutes for treatment in an acute care hospital. Limited studies of the home hospital model have demonstrated that a sizeable proportion of acute care can be delivered in the home with equal quality and safety, reduced cost, and improved patient experience.


Description:

Hospitals are the standard of care for acute illness in the United States, but hospital care is expensive and often unsafe, especially for older individuals. While admitted, 20% suffer delirium, over 5% contract hospital-acquired infections, and most lose functional status that is never regained. Timely access to inpatient care is poor: many hospital wards are typically over 100% capacity, and emergency department waits can be protracted. Moreover, hospital care is increasingly costly: many internal medicine admissions have a negative margin (i.e., expenditures exceed hospital revenues) and incur patient debt. The investigators propose a home hospital model of care that substitutes for treatment in an acute care hospital. Studies of the home hospital model have demonstrated that a sizeable proportion of acute care can be delivered in the home with equal quality and safety, 20% reduced cost, and 20% improved patient experience. While this is the standard of care in several developed countries, only 2 non-randomized demonstration projects have been conducted in the United States, each with highly local needs. Taken together, home hospital evidence is promising but falls short due to non-robust experimental design, failure to implement modern medical technology, and poor enlistment of community support. The home hospital module offers most of the same medical components that are standard of care in an acute care hospital. The typical staff (medical doctor [MD], registered nurse [RN], case manager), diagnostics (blood tests, vital signs, telemetry, x-ray, and ultrasound), intravenous therapy, and oxygen/nebulizer therapy will all be available for home hospital. Optional deployment of food services, home health aide, physical therapist, occupational therapist, and social worker will be tailored to patient need. Home hospital improves upon the components of a typical ward's standard of care in several ways: Point of care blood diagnostics (results at the bedside in <5 minutes); Minimally invasive continuous vital signs, telemetry, activity tracking, and sleep tracking; On-demand 24/7 clinician video visits; 4 to 1 patient to MD ratio, compared to typical 16 to 1; Ambulatory/portable infusion pumps that can be worn on the hip; Optional access to a personal home health aide Should a matter be emergent (that is, requiring in-person assistance in less than 20 minutes), then 9-1-1 will be called and the patient will be returned to the hospital immediately. In previous iterations of home hospital this happens in about 2% of patients. Clinical parameters measured will be at the discretion of the physician and nurse, who treat the participant following evidence-based practice guidelines, just as in the usual care setting. In addition, the investigators will be tracking a wide variety of measures of quality and safety, including some measures tailored to each primary diagnosis.


Recruitment information / eligibility

Status Recruiting
Enrollment 3000
Est. completion date September 2023
Est. primary completion date September 2023
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Resides within either a 5-mile or 20 minute driving radius of emergency department - Has capacity to consent to study OR can assent to study and has proxy who can consent - >= 18 years-old - Can identify a potential caregiver who agrees to stay with patient for first 24 hours of admission. Caregiver must be competent to call care team if a problem is evident to her/him. After 24 hours, this caregiver should be available for as-needed spot checks on the patient. This criterion may be waived for highly competent patients at the patient and clinician's discretion. - Primary or possible diagnosis of cellulitis, heart failure, complicated urinary tract infection, pneumonia, COPD/asthma, other infection, chronic kidney disease, malignant pain, diabetes and its complications, gout flare, hypertensive urgency, previously diagnosed atrial fibrillation with rapid ventricular response, anticoagulation needs, or a patient who desires only medical management that requires inpatient admission, as determined by the emergency room team. Exclusion Criteria: - Undomiciled - No working heat (October-April), no working air conditioning if forecast > 80°F (June-September), or no running water - On methadone requiring daily pickup of medication - In police custody - Resides in facility that provides on-site medical care (e.g., skilled nursing facility) - Domestic violence screen positive - Acute delirium, as determined by the Confusion Assessment Method - Cannot establish peripheral access in emergency department (or access requires ultrasound guidance) - Secondary condition: end-stage renal disease, acute myocardial infarction, acute cerebral vascular accident, acute hemorrhage - Primary diagnosis requires multiple or routine administrations of intravenous narcotics for pain control - Cannot independently ambulate to bedside commode - As deemed by on-call medical doctor, patient likely to require any of the following procedures: computed tomography, magnetic resonance imaging, endoscopic procedure, blood transfusion, cardiac stress test, or surgery - High risk for clinical deterioration - Home hospital census is full (maximum 5 patients at any time)

Study Design


Intervention

Other:
Home Hospitalization
See above

Locations

Country Name City State
United States Brigham and Women's Faulkner Hospital Boston Massachusetts
United States Brigham and Women's Hospital Boston Massachusetts

Sponsors (1)

Lead Sponsor Collaborator
Brigham and Women's Hospital

Country where clinical trial is conducted

United States, 

References & Publications (7)

Counsell SR, Holder CM, Liebenauer LL, Palmer RM, Fortinsky RH, Kresevic DM, Quinn LM, Allen KR, Covinsky KE, Landefeld CS. Effects of a multicomponent intervention on functional outcomes and process of care in hospitalized older patients: a randomized controlled trial of Acute Care for Elders (ACE) in a community hospital. J Am Geriatr Soc. 2000 Dec;48(12):1572-81. — View Citation

Cryer L, Shannon SB, Van Amsterdam M, Leff B. Costs for 'hospital at home' patients were 19 percent lower, with equal or better outcomes compared to similar inpatients. Health Aff (Millwood). 2012 Jun;31(6):1237-43. doi: 10.1377/hlthaff.2011.1132. — View Citation

Fong TG, Tulebaev SR, Inouye SK. Delirium in elderly adults: diagnosis, prevention and treatment. Nat Rev Neurol. 2009 Apr;5(4):210-20. doi: 10.1038/nrneurol.2009.24. Review. — View Citation

Hung WW, Ross JS, Farber J, Siu AL. Evaluation of the Mobile Acute Care of the Elderly (MACE) service. JAMA Intern Med. 2013 Jun 10;173(11):990-6. doi: 10.1001/jamainternmed.2013.478. — View Citation

Leff B, Burton L, Mader SL, Naughton B, Burl J, Inouye SK, Greenough WB 3rd, Guido S, Langston C, Frick KD, Steinwachs D, Burton JR. Hospital at home: feasibility and outcomes of a program to provide hospital-level care at home for acutely ill older patients. Ann Intern Med. 2005 Dec 6;143(11):798-808. — View Citation

Levine DM, Ouchi K, Blanchfield B, Diamond K, Licurse A, Pu CT, Schnipper JL. Hospital-Level Care at Home for Acutely Ill Adults: a Pilot Randomized Controlled Trial. J Gen Intern Med. 2018 May;33(5):729-736. doi: 10.1007/s11606-018-4307-z. Epub 2018 Feb 6. — View Citation

Montalto M. The 500-bed hospital that isn't there: the Victorian Department of Health review of the Hospital in the Home program. Med J Aust. 2010 Nov 15;193(10):598-601. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Other Total reimbursement, 30-days post discharge Exploratory Day of admission to 30-days post-discharge
Other Intravenous medications, days Exploratory From date of admission to date of discharge, an expected average of 4 days
Other Intravenous fluids, days Exploratory; the number of days intravenous fluids (for example, normal saline) were received by the patient. From date of admission to date of discharge, an expected average of 4 days
Other Intravenous diuretics, days Exploratory; the number of days intravenous diuretics (for example, furosemide) were received by the patient. From date of admission to date of discharge, an expected average of 4 days
Other Intravenous antibiotics, days Exploratory; the number of days intravenous antibiotics (for example, ceftriaxone) were received by the patient. From date of admission to date of discharge, an expected average of 4 days
Other Supplemental oxygen required, days Exploratory From date of admission to date of discharge, an expected average of 4 days
Other Nebulizer treatment, days Exploratory From date of admission to date of discharge, an expected average of 4 days
Other Medical Doctor sessions, # notes Exploratory From date of admission to date of discharge, an expected average of 4 days
Other Consultant Sessions, # notes Exploratory From date of admission to date of discharge, an expected average of 4 days
Other Physical therapy/occupational therapy sessions, # notes Exploratory From date of admission to date of discharge, an expected average of 4 days
Other Primary care provider follow-up within 14 days, y/n Exploratory up to 14 days from day of discharge
Other Skilled nursing facility usage, days Exploratory; the number of days a patient spent in a skilled nursing facility. up to 30 days from day of discharge
Other Home health utilization, days Exploratory up to 30 days from day of discharge
Other Fall, y/n Exploratory From date of admission to date of discharge, an expected average of 4 days
Other Hospital-acquired deep vein thrombosis or pulmonary embolism, y/n Exploratory From date of admission to date of discharge, an expected average of 4 days
Other Hospital-acquired pressure ulcer, y/n Exploratory From date of admission to date of discharge, an expected average of 4 days
Other Hospital-acquired thrombophlebitis at peripheral IV site, y/n Exploratory From date of admission to date of discharge, an expected average of 4 days
Other Hospital-acquired catheter-associated urinary tract infection, y/n Exploratory From date of admission to date of discharge, an expected average of 4 days
Other Hospital-acquired Clostridium difficile infection, y/n Exploratory From date of admission to date of discharge, an expected average of 4 days
Other Hospital-acquired methicillin resistant staphylococcus aureus infection, y/n Exploratory From date of admission to date of discharge, an expected average of 4 days
Other All-cause mortality, y/n Exploratory From date of admission to date of discharge, an expected average of 4 days
Other Unplanned mortality, y/n Exploratory From date of admission to date of discharge, an expected average of 4 days
Other Post-discharge all-cause mortality, y/n Exploratory Day of discharge to 30 days later
Other Post-discharge unplanned mortality, y/n Exploratory Day of discharge to 30 days later
Other New arrhythmia, y/n Heart failure patients only; Exploratory From date of admission to date of discharge, an expected average of 4 days
Other Hypokalemia, y/n Heart failure patients only; Exploratory From date of admission to date of discharge, an expected average of 4 days
Other Acute Kidney Injury, y/n Heart failure patients only; Exploratory From date of admission to date of discharge, an expected average of 4 days
Other Mean Likert scale pain score, 0-10 Exploratory From date of admission to date of discharge, an expected average of 4 days
Other Hours of sleep per night, # Exploratory From date of admission to date of discharge, an expected average of 4 days
Other Hours of activity per night, # Exploratory From date of admission to date of discharge, an expected average of 4 days
Other Hours of sitting upright per night, # Exploratory From date of admission to date of discharge, an expected average of 4 days
Other Pneumococcal vaccination if appropriate, y/n Pneumonia patients only; Exploratory From date of admission to date of discharge, an expected average of 4 days
Other Influenza vaccination if appropriate, y/n Pneumonia patients only; Exploratory From date of admission to date of discharge, an expected average of 4 days
Other Smoking cessation counseling if appropriate, y/n Pneumonia and heart failure patients only; Exploratory From date of admission to date of discharge, an expected average of 4 days
Other Evaluation of ejection fraction as assessed by echocardiogram or other appropriate study, scheduled or completed, if not done within 1 year, y/n Heart failure patients only; Exploratory; Whether or not an appropriate study occurred and/or was scheduled if not done within 1 year; appropriate studies include cardiac magnetic resonance imaging, radionuclide ventriculography, single photon emission computed tomography myocardial perfusion imaging, or left ventriculography From date of admission to date of discharge, an expected average of 4 days
Other Angiotensin converting enzyme inhibitor or angiotensin receptor blocker for heart failure with reduced ejection fraction (ejection fraction < 40%), y/n Heart failure patients only; Exploratory From date of admission to date of discharge, an expected average of 4 days
Other Beta blocker for heart failure with reduced ejection fraction (ejection fraction < 40%), y/n Heart failure patients only; Exploratory From date of admission to date of discharge, an expected average of 4 days
Other Aldosterone antagonist for heart failure with reduced ejection fraction (ejection fraction < 40%), y/n Heart failure patients only; Exploratory From date of admission to date of discharge, an expected average of 4 days
Other Lipid lowering for coronary artery disease, peripheral vascular disease, cerebrovascular accident, or diabetes, y/n Heart failure patients only; Exploratory From date of admission to date of discharge, an expected average of 4 days
Other Smoking status post-discharge, current/never/quit Heart failure and pneumonia patients only; Exploratory; Self-report of smoking status: current/never/quit. From date of admission to date of discharge, an expected average of 4 days
Other Use of inappropriate medications in the elderly, y/n Exploratory; using Screening Tool of Older Persons' potentially inappropriate Prescriptions (STOPP) and Beers criteria From date of admission to date of discharge, an expected average of 4 days
Other Use of Foley catheter, y/n Exploratory From date of admission to date of discharge, an expected average of 4 days
Other Use of restraints, y/n Exploratory From date of admission to date of discharge, an expected average of 4 days
Other >3 medications added to medication list, y/n Exploratory; comparison made between preadmission and discharge medication list Date of discharge, an expected average of 4 days after the date of admission
Other Patient health questionnaire-2, score Exploratory At admission, at discharge (an expected average of 4 days after the date of admission), and at 30 days after discharge
Other Patient-Reported Outcomes Measurement Information System Emotional Support Short Form 4a, score Exploratory: I have someone who will listen to me when I need to talk I have someone to confide in or talk to about myself or my problems I have someone who makes me feel appreciated I have someone to talk with when I have a bad day Scale for each: never, rarely, sometimes, usually, always At admission, at discharge (an expected average of 4 days after the date of admission), and at 30 days after discharge
Other Days at home since discharge Exploratory 30 days after discharge
Other Walk around ward/home, y/n Exploratory Date of discharge, an expected average of 4 days after the date of admission
Other Get to (non-commode) bathroom, y/n Exploratory Date of discharge, an expected average of 4 days after the date of admission
Other Walk 1 flight of stairs, y/n Exploratory Date of discharge, an expected average of 4 days after the date of admission
Other Visit with friends/family, y/n Exploratory Date of discharge, an expected average of 4 days after the date of admission
Other Walk outside around my home, y/n Exploratory Date of discharge, an expected average of 4 days after the date of admission
Other Go shopping, y/n Exploratory Date of discharge, an expected average of 4 days after the date of admission
Other Time from admission decision to assessment by research assistant, minutes Exploratory On the first day of admission, a maximum 24 hour period
Other Time from research assistant assessment to emergency department dismissal, minutes Exploratory On the first day of admission, a maximum 24 hour period
Other Time from arrival home to medical doctor evaluation, minutes Exploratory On the first day of admission, a maximum 24 hour period
Other Time from arrival home to registered nurse evaluation, minutes Exploratory On the first day of admission, a maximum 24 hour period
Other Mean registered nurse to patient ratio Exploratory From date of admission to date of discharge, an expected average of 4 days
Other Total registered nurse visits, # Exploratory From date of admission to date of discharge, an expected average of 4 days
Other Total "on call" medical doctor interactions (video or phone), # Exploratory From date of admission to date of discharge, an expected average of 4 days
Other Total "on call" medical doctor in-person visits Exploratory From date of admission to date of discharge, an expected average of 4 days
Other Duration of 1st registered nurse visit, minutes Exploratory On the first day of admission, a maximum 24 hour period
Other Mean duration of subsequent registered nurse visit, minutes Exploratory From date of admission to date of discharge, an expected average of 4 days
Primary Total direct cost of hospitalization, $ From date of admission to date of discharge, an expected average of 4 days
Secondary Direct margin, $ Direct margin from total cost of hospitalization From date of admission to date of discharge, an expected average of 4 days
Secondary Direct margin, modeled with backfill Backfill uses a model that estimates the cost of patients who take the place of home hospital patients From date of admission to date of discharge, an expected average of 4 days
Secondary Total cost, 30-day post discharge Day of admission to 30-days post-discharge
Secondary Length of stay, days From date of admission to date of discharge, an expected average of 4 days
Secondary Imaging, # Count of any diagnostic imaging (for example, x-ray, computed tomography, magnetic resonance, ultrasound, and nuclear imaging) that occurred through the course of the hospitalization. From date of admission to date of discharge, an expected average of 4 days
Secondary Lab orders, # Count of any lab order (for example, basic metabolic panel, complete blood count, hepatic function panel) that occurred through the course of the hospitalization. From date of admission to date of discharge, an expected average of 4 days
Secondary All-cause readmission(s) after index, # Day of discharge to 30 days later
Secondary All-cause readmission(s) after index, y/n Day of discharge to 30 days later
Secondary Unplanned readmission(s) after index, # Day of discharge to 30 days later
Secondary Unplanned readmission(s) after index, y/n Day of discharge to 30 days later
Secondary Emergency Department observation stay(s) after index hospitalization, # Day of discharge to 30 days later
Secondary Emergency Department observation stay(s) after index hospitalization, y/n Day of discharge to 30 days later
Secondary Emergency Department visit(s) after index hospitalization, # Day of discharge to 30 days later
Secondary Emergency Department visit(s) after index hospitalization, y/n Day of discharge to 30 days later
Secondary Delirium, y/n From date of admission to date of discharge, an expected average of 4 days
Secondary Transfer back to hospital, y/n From date of admission to date of discharge, an expected average of 4 days
Secondary Hours of sleep per day, # From date of admission to date of discharge, an expected average of 4 days
Secondary Hours of activity per day, # From date of admission to date of discharge, an expected average of 4 days
Secondary Hours of sitting upright per day, # From date of admission to date of discharge, an expected average of 4 days
Secondary Steps per day, # From date of admission to date of discharge, an expected average of 4 days
Secondary EuroQol-5D-5L, composite score At admission, at discharge (the day the patient leaves the hospital environment), and at 30 days after discharge
Secondary Short Form 1 1-5 Likert scale: Excellent, very good, good, fair poor 30 days prior to admission (asked on day of admission), at admission, at discharge (the day the patient leaves the hospital environment), and at 30 days after discharge
Secondary Activities of daily living, score 30 days prior to admission (asked on day of admission), at admission, at discharge (the day the patient leaves the hospital environment), and at 30 days after discharge
Secondary Instrumental activities of daily living, score 30 days prior to admission (asked on day of admission), at admission, at discharge (the day the patient leaves the hospital environment), and at 30 days after discharge
Secondary 3-item Care Transition Measure, score 30 days after discharge
Secondary Picker Experience Questionnaire, score 30 days after discharge
Secondary Global satisfaction with care, score 30 days after discharge
Secondary Qualitative interview 30 days after discharge
See also
  Status Clinical Trial Phase
Completed NCT04624425 - Additional Effects of Segmental Breathing In Asthma N/A
Terminated NCT04410523 - Study of Efficacy and Safety of CSJ117 in Patients With Severe Uncontrolled Asthma Phase 2
Active, not recruiting NCT03927820 - A Pharmacist-Led Intervention to Increase Inhaler Access and Reduce Hospital Readmissions (PILLAR) N/A
Completed NCT04617015 - Defining and Treating Depression-related Asthma Early Phase 1
Recruiting NCT03694158 - Investigating Dupilumab's Effect in Asthma by Genotype Phase 4
Terminated NCT04946318 - Study of Safety of CSJ117 in Participants With Moderate to Severe Uncontrolled Asthma Phase 2
Completed NCT04450108 - Vivatmo Pro™ for Fractional Exhaled Nitric Oxide (FeNO) Monitoring in U.S. Asthmatic Patients N/A
Completed NCT03086460 - A Dose Ranging Study With CHF 1531 in Subjects With Asthma (FLASH) Phase 2
Completed NCT01160224 - Oral GW766944 (Oral CCR3 Antagonist) Phase 2
Completed NCT03186209 - Efficacy and Safety Study of Benralizumab in Patients With Uncontrolled Asthma on Medium to High Dose Inhaled Corticosteroid Plus LABA (MIRACLE) Phase 3
Completed NCT02502734 - Effect of Inhaled Fluticasone Furoate on Short-term Growth in Paediatric Subjects With Asthma Phase 3
Completed NCT01715844 - L-Citrulline Supplementation Pilot Study for Overweight Late Onset Asthmatics Phase 1
Terminated NCT04993443 - First-In-Human Study to Evaluate the Safety, Tolerability, Immunogenicity, and Pharmacokinetics of LQ036 Phase 1
Completed NCT02787863 - Clinical and Immunological Efficiency of Bacterial Vaccines at Adult Patients With Bronchopulmonary Pathology Phase 4
Recruiting NCT06033833 - Long-term Safety and Efficacy Evaluation of Subcutaneous Amlitelimab in Adult Participants With Moderate-to-severe Asthma Who Completed Treatment Period of Previous Amlitelimab Asthma Clinical Study Phase 2
Completed NCT03257995 - Pharmacodynamics, Safety, Tolerability, and Pharmacokinetics of Two Orally Inhaled Indacaterol Salts in Adult Subjects With Asthma. Phase 2
Completed NCT02212483 - Clinical Effectiveness and Economical Impact of Medical Indoor Environment Counselors Visiting Homes of Asthma Patients N/A
Recruiting NCT04872309 - MUlti-nuclear MR Imaging Investigation of Respiratory Disease-associated CHanges in Lung Physiology
Withdrawn NCT01468805 - Childhood Asthma Reduction Study N/A
Recruiting NCT05145894 - Differentiation of Asthma/COPD Exacerbation and Stable State Using Automated Lung Sound Analysis With LungPass Device